Soleimani M, Jalilvand A
Sci Rep. 2025; 15(1):7450.
PMID: 40032988
PMC: 11876366.
DOI: 10.1038/s41598-025-91246-y.
Zhou Y, Ahearn Y, Lokugamage K, Alvarado R, Estes L, Meyers W
bioRxiv. 2024; .
PMID: 39605585
PMC: 11601229.
DOI: 10.1101/2024.11.11.622995.
Joyce J, Moore G, Goswami P, Harrell T, Taylor T, Hawks S
Int J Mol Sci. 2024; 25(15).
PMID: 39125815
PMC: 11311394.
DOI: 10.3390/ijms25158245.
Mkolo N, Naidoo C, Kadye R, Obi C, Iweriebor B, Olaokun O
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065672
PMC: 11279959.
DOI: 10.3390/ph17070821.
Xu Q, Yu D, Fan X, Cui H, Dai Q, Zhong X
Chin J Integr Med. 2024; 31(1):83-95.
PMID: 38958885
DOI: 10.1007/s11655-024-3909-z.
The alarmin IL-33 exacerbates pulmonary inflammation and immune dysfunction in SARS-CoV-2 infection.
Wang H, Hosakote Y, Boor P, Yang J, Zhang Y, Yu X
iScience. 2024; 27(6):110117.
PMID: 38947521
PMC: 11214397.
DOI: 10.1016/j.isci.2024.110117.
Microfluidic Biochips for Single-Cell Isolation and Single-Cell Analysis of Multiomics and Exosomes.
Wang C, Qiu J, Liu M, Wang Y, Yu Y, Liu H
Adv Sci (Weinh). 2024; 11(28):e2401263.
PMID: 38767182
PMC: 11267386.
DOI: 10.1002/advs.202401263.
Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease.
Heiss J, Ray-Chaudhury A, Kleiner D, Ehrlich D, Scott G, Edwards N
Mov Disord. 2024; 39(8):1412-1417.
PMID: 38718138
PMC: 11341257.
DOI: 10.1002/mds.29820.
Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence.
Bradley C, Wang C, Gordon A, Wen A, Luna P, Cooke M
Nat Microbiol. 2024; 9(5):1382-1392.
PMID: 38649410
PMC: 11384275.
DOI: 10.1038/s41564-024-01655-4.
SARS-CoV-2 mutant spectra as variant of concern nurseries: endless variation?.
Martinez-Gonzalez B, Soria M, Minguez P, Lorenzo-Redondo R, Salar-Vidal L, Lopez-Garcia A
Front Microbiol. 2024; 15:1358258.
PMID: 38559344
PMC: 10979541.
DOI: 10.3389/fmicb.2024.1358258.
Variant mutation in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation.
Kubinski H, Despres H, Johnson B, Schmidt M, Jaffrani S, Mills M
bioRxiv. 2024; .
PMID: 38559000
PMC: 10979914.
DOI: 10.1101/2024.03.08.584120.
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity.
Yang Z, Johnson B, Meliopoulos V, Ju X, Zhang P, Hughes M
Cell Rep. 2024; 43(3):113965.
PMID: 38492217
PMC: 11044841.
DOI: 10.1016/j.celrep.2024.113965.
Recombinant Rod Domain of Vimentin Reduces SARS-CoV-2 Viral Replication by Blocking Spike Protein-ACE2 Interactions.
Lam F, Brown C, Ronca S
Int J Mol Sci. 2024; 25(5).
PMID: 38473724
PMC: 10931652.
DOI: 10.3390/ijms25052477.
SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle.
Walia K, Sharma A, Paul S, Chouhan P, Kumar G, Ringe R
Nat Commun. 2024; 15(1):2053.
PMID: 38448435
PMC: 10918171.
DOI: 10.1038/s41467-024-46417-2.
Neutralising antibodies against SARS-CoV-2 give important information on Covid-19 epidemic evolution in Rabat, Morocco, March 2020-February 2021.
Touil N, Touzani C, Benaissa E, Kasouati J, Rhazzar Z, Annaz H
Afr Health Sci. 2024; 23(3):400-405.
PMID: 38357173
PMC: 10862607.
DOI: 10.4314/ahs.v23i3.46.
Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage.
Quarleri J, Delpino M
World J Hepatol. 2024; 16(1):1-11.
PMID: 38313242
PMC: 10835487.
DOI: 10.4254/wjh.v16.i1.1.
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.
Raglow Z, Surie D, Chappell J, Zhu Y, Martin E, Kwon J
Lancet Microbe. 2024; 5(3):e235-e246.
PMID: 38286131
PMC: 11849777.
DOI: 10.1016/S2666-5247(23)00336-1.
COVID-19 on Oral Health: A New Bilateral Connection for the Pandemic.
Bellocchio L, Dipalma G, Inchingolo A, Inchingolo A, Ferrante L, Del Vecchio G
Biomedicines. 2024; 12(1).
PMID: 38255167
PMC: 10813615.
DOI: 10.3390/biomedicines12010060.
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects.
Zhang J, Hom K, Zhang C, Nasr M, Gerzanich V, Zhang Y
Pathogens. 2024; 13(1).
PMID: 38251382
PMC: 10819734.
DOI: 10.3390/pathogens13010075.
High-throughput drug screen identifies calcium and calmodulin inhibitors that reduce JCPyV infection.
Bond A, Crocker M, Wilczek M, DuShane J, Sandberg A, Bennett L
Antiviral Res. 2024; 222:105817.
PMID: 38246207
PMC: 10922812.
DOI: 10.1016/j.antiviral.2024.105817.